Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
³ëº¸³ÑÁ¤0.5mg - »õâ
|
Novo Nordisk |
E08720211 | Repaglinide | Àü¹®ÀǾàǰ | ±Þ¿© |
|
³ëº¸³ÑÁ¤1mg - »õâ
|
Novo Nordisk |
E08720201 | Repaglinide | Àü¹®ÀǾàǰ | ±Þ¿© |
|
³ëº¸³ÑÁ¤2mg - »õâ
|
Novo Nordisk |
E08720191 | Repaglinide | Àü¹®ÀǾàǰ | ±Þ¿© |
| repaglinide |
an oral hypoglycemic agent that acts by stimulating the release of insulin from functioning beta cells in the pancreatic islet tissue; used, often in combination with metformin, in the treatment of type 2 diabetes mellitus.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|